To explore the potential correlations between IQGAP3 expression and pertinent clinical-pathological parameters in glioma patients, a Chi-square test was meticulously executed within both the TCGA-GBM and TCGA-LGG cohorts. The gene discussed is IQGAP3; the disease is central nervous system cancer.